StairMed Showcases Breakthrough in Brain-Computer Interface on CCTV, Highlighting China's Innovation Power
StairMed
Developer of Implantable Brain-Computer Interface Technology
"A coin-sized implant, electrodes 100 times thinner than a hair, connecting the brain to smart devices"
Recently, CCTV Finance Channel (CCTV-2"Hello 15th Five-Year Plan" series report aired, focusing on brain-computer interface, a strategically emerging industry key supported by China's "15th Five-Year Plan". As a representative company in this field, StairMed was invited to participate in the special report.。StairMedFounder Dr. Xue LiAndProfessor Wu Jinsong, Chief Physician of the Department of Neurosurgery at Huashan Hospital Affiliated to Fudan UniversityJointly shared the latest breakthroughs and practical progress in China's core technologies and clinical applications of brain-computer interfaces.
National Strategy Focuses on "15th Five-Year Plan" Layout for Frontier Technologies
InIn the macro blueprint of the "15th Five-Year Plan," brain-computer interface has been listed as one of the key frontier technology directions for future development. This technology is not only a highland of interdisciplinary fields such as neuroscience, artificial intelligence, and materials science, but also considered...Future new economic growth points.
It is against this backdrop of the times that StairMed has become a brain-computer interface leader in China, relying on its independent innovation capabilities and clinical transformation strengths.IndustryAn important participant and promoter.
The World's Smallest Brain-Controlled Implant Represents an Innovative Breakthrough of China's Intelligent Manufacturing
In the program, Dr. Li Xue, founder of StairMed, presented the company's research achievements.——The world's smallest brain-controlled implant.
The diameter of this device is only26Millimeters, equivalent to the size of a coin, while the diameter of the ultra-flexible electrode at the front end is only one-hundredth the thickness of a hair, enabling precise neural signal acquisition and response within milliseconds, with signal delay below50Milliseconds.
"Now, most of our components have achieved independent control, and the next step will be to fully realize complete chain independent control," said Dr. Li Xue on the program. She also pointed out that over the past few years, with the improvement of the national innovation system and policy support, the industrial ecosystem from upstream core materials to downstream medical applications is rapidly forming. China's brain-computer interface industry is now entering a critical phase of transitioning from 'laboratory breakthroughs' to 'industrial implementation.'
Significant Results from Clinical Trials Restore Patients' Self-Care Abilities
At the clinical application level, StairMed has collaborated with Huashan Hospital Affiliated to Fudan University to jointly launchProspective Clinical Trial of Invasive Brain-Computer InterfaceProfessor Wu Jinsong introduced in the program:"Based on the current experimental results, the function of motion control has been initially achieved, helping patients rebuild some self-care abilities."
This means that China's brain-computer interface technology has moved from the basic research stage to the clinically verifiable and applicable stage. In the future,"During the '15th Five-Year Plan' period, the team will further expand into directions such as motor brain-computer interfaces, speech synthesis, visual reconstruction, and neuromodulation, bringing hope to more patients."
From technological breakthroughs to clinical validation, StairMed is driving China's brain-computer interface technology onto the global stage with its independent innovation capabilities.
In ChinaUnder the guidance of the "Fifteenth Five-Year" strategy, StairMed will continue to focus on the field of brain-computer interface medical devices, collaborating with clinical and research institutions.Industry Partners, accelerate the implementation and popularization of technology, and contribute to the construction of Healthy China and the development of future medical technology.
